Concepedia

Hiroya Takiuchi

HT

Statistics

Publications

44

Citations

4K

H-Index

26

Active since

1995

Affiliations

Osaka Medical and Pharmaceutical University(Current)

National Cancer Center Hospital East

Shizuoka Cancer Center

Aichi Cancer Center

Saitama Cancer Center

Hiroya Takiuchi is an author at Osaka Medical and Pharmaceutical University specializing in medicine, oncology, and chemotherapy.

Publications per year

1995–2014

44

Publications

44

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer

Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada et al. · International Journal of Clinical Oncology · 2011 · 713 citations

, , +16

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Narikazu Boku, Seiichiro Yamamoto, Haruhiko Fukuda et al. · The Lancet Oncology · 2009 · 592 citations

, , +13

Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society

Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyama et al. · Esophagus · 2014 · 458 citations · Full text

, , +11

Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II–III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)

Ken Kato, Kei Muro, Keiko Minashi et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 349 citations

, , +14

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)

Kei Muro, Narikazu Boku, Yasuhiro Shimada et al. · The Lancet Oncology · 2010 · 219 citations

, , +13

1–5 of 44